Norris Medicines Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 210607,
    "name": "Norris Medicines",
    "stock_name": "Norris Medicines",
    "full_name": "Norris Medicines Ltd",
    "name_url": "stocks-analysis/norris-medicines",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "14.00",
    "chg": -0.18,
    "chgp": "-1.27%",
    "dir": -1,
    "prev_price": "14.18",
    "mcapval": "14.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524414,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 4,
    "sector_id": 79,
    "indexname": "India SENSEX",
    "isin": "INE744C01029",
    "curr_date": "Jun 10, 03:30 PM",
    "curr_time": "21:16 PM",
    "last_traded_at": "Jun 10, 03:30 PM IST",
    "bse_nse_vol": "1.79 k",
    "exc_status": "Active",
    "traded_date": "Jun 10, 2026",
    "traded_date_str": "2026 06 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/norris-medicines-210607-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Norris Medicines Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-norris-medicines-ltd-latest-results-good-or-bad-4024820",
        "imagepath": "",
        "date": "2026-05-31 19:21:58",
        "description": "Norris Medicines Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company reported a net profit of ₹0.05 crore, a notable recovery from a loss in the same quarter last year. However, this profitability comes amidst significant revenue challenges, with net sales declining to ₹1.41 crores, representing a substantial decrease of 48.16% year-on-year and a dramatic 56.88% drop from the previous quarter.\n\nThe operating margin showed a remarkable improvement, rising to 21.99% compared to just 2.57% in Q4 FY25, indicating effective cost management despite the revenue contraction. This margin expansion raises questions about the sustainability of profitability, as it appears primarily driven by cost containment rather than revenue growth.\n\nThe company's financial position remains precarious, with a negative book value of ₹14.98 per share, reflecting accumulated los..."
      },
      {
        "title": "Norris Medicines Q4 FY26: Micro-Cap Pharma Trader Posts Surprise Profit Amid Severe Revenue Decline",
        "link": "https://www.marketsmojo.com/news/result-analysis/norris-medicines-q4-fy26-micro-cap-pharma-trader-posts-surprise-profit-amid-severe-revenue-decline-4024450",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NorrisMedicines_quaterlyResult_4024450.png",
        "date": "2026-05-30 23:46:37",
        "description": "Norris Medicines Limited, a micro-cap pharmaceutical trading and distribution company, reported a net profit of ₹0.05 crores for Q4 FY26 (January-March 2026), marking a dramatic reversal from the ₹0.23 crore loss recorded in the same quarter last year. However, this profitability came against a backdrop of severe revenue contraction, with quarterly net sales plummeting 48.16% year-on-year to ₹1.41 crores. The company's shares, trading at ₹13.25 with a market capitalisation of just ₹14.00 crores, remain under significant pressure as investors grapple with the sustainability of this turnaround."
      },
      {
        "title": "When is the next results date for Norris Medicines Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-norris-medicines-ltd-4015276",
        "imagepath": "",
        "date": "2026-05-26 23:20:44",
        "description": "The next results date for Norris Medicines Ltd is scheduled for 30 May 2026...."
      },
      {
        "title": "Norris Medicines Ltd Falls to 52-Week Low of Rs 12 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3909902",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NorrisMedicines_priceRelatedfactors_3909902.png",
        "date": "2026-03-24 09:50:06",
        "description": "For the fourth consecutive session, Norris Medicines Ltd has closed lower, culminating in a fresh 52-week low of Rs 12 on 24 Mar 2026. This marks a 14.09% decline over the past four days, underscoring sustained selling pressure despite some pockets of strength in the broader market."
      },
      {
        "title": "Norris Medicines Ltd Falls to 52-Week Low of Rs 12.45 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-falls-to-52-week-low-of-rs1245-3907569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NorrisMedicines_priceRelatedfactors_3907569.png",
        "date": "2026-03-23 11:45:54",
        "description": ""
      }
    ],
    "total": 257,
    "sid": "210607",
    "stock_news_url": "https://www.marketsmojo.com/news/norris-medicines-210607"
  },
  "announcements": [
    {
      "caption": "Outcome Of Board Meeting Held Today I.E. 30Th May 2026.",
      "datetime": "30-May-2026",
      "details": "As per attachment.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 30Th May 2026.",
      "datetime": "30-May-2026",
      "details": "As per attachment.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "30-May-2026",
      "details": "Appointment of Internal Auditor w.e.f 30.05.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Norris Medicines Ltd latest results good or bad?

2026-05-31 19:21:58

Norris Medicines Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company reported a net profit of ₹0.05 crore, a notable recovery from a loss in the same quarter last year. However, this profitability comes amidst significant revenue challenges, with net sales declining to ₹1.41 crores, representing a substantial decrease of 48.16% year-on-year and a dramatic 56.88% drop from the previous quarter. The operating margin showed a remarkable improvement, rising to 21.99% compared to just 2.57% in Q4 FY25, indicating effective cost management despite the revenue contraction. This margin expansion raises questions about the sustainability of profitability, as it appears primarily driven by cost containment rather than revenue growth. The company's financial position remains precarious, with a negative book value of ₹14.98 per share, reflecting accumulated los...

Read full news article

Norris Medicines Q4 FY26: Micro-Cap Pharma Trader Posts Surprise Profit Amid Severe Revenue Decline

2026-05-30 23:46:37

Norris Medicines Limited, a micro-cap pharmaceutical trading and distribution company, reported a net profit of ₹0.05 crores for Q4 FY26 (January-March 2026), marking a dramatic reversal from the ₹0.23 crore loss recorded in the same quarter last year. However, this profitability came against a backdrop of severe revenue contraction, with quarterly net sales plummeting 48.16% year-on-year to ₹1.41 crores. The company's shares, trading at ₹13.25 with a market capitalisation of just ₹14.00 crores, remain under significant pressure as investors grapple with the sustainability of this turnaround.

Read full news article

When is the next results date for Norris Medicines Ltd?

2026-05-26 23:20:44

The next results date for Norris Medicines Ltd is scheduled for 30 May 2026....

Read full news article

Norris Medicines Ltd Falls to 52-Week Low of Rs 12 as Sell-Off Deepens

2026-03-24 09:50:06

For the fourth consecutive session, Norris Medicines Ltd has closed lower, culminating in a fresh 52-week low of Rs 12 on 24 Mar 2026. This marks a 14.09% decline over the past four days, underscoring sustained selling pressure despite some pockets of strength in the broader market.

Read full news article

Norris Medicines Ltd Falls to 52-Week Low of Rs 12.45 as Sell-Off Deepens

2026-03-23 11:45:54

Read full news article

View All News